A review of Huntington's disease

International Journal of Psychiatry in Clinical Practice

Volumn 1, Issue 2, 1997, Pages 135-140

  O'Shea, Brian ^a,b  

^a Newcastle Hospital   (Ireland)

^b Greystones Co   (Ireland)

Author keywords

Counselling; Genetic treatment; Huntington's disease; Predictive testing; Psychiatry

Indexed keywords

EID: 2842583569     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509709024715     Document Type: Article

References (68)

1. O'Shea B (1984) Huntington's disease. Ir J Psychiatry 5: 4-12.
2. O'Shea B, Falvey J (1988) Huntington's disease: update of the literature. Ir J Psychol Med 5: 61-70.
3. O'Shea B, Falvey J (1991) Juvenile Huntington's disease. Ir J Psychol Med 8: 149-153.
4. Gusella JF, Wexler NS, Conneally PM et al (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306: 234-238.
5. Wang HS, Greenberg CR, Hayden M (1985) Subregional assignment of a DNA marker (G8) linked to Huntington disease by in situ hybridisation. Am J Hum Genet 37: A121.
6. Gilliam TC, Tanzi RE, Haines JL et al (1987) Localisation of the Huntington's disease gene to a small segment of chromosome 4 flanked by D4S 10 and the telomere. Cell 50: 565-571.
7. Kremer B, Goldberg P, Andrew SE et al (1994) A worldwide study of the Huntington's disease mutation: the sensitivity and specificity of measuring CAG repeats. N Engl J Med 330: 1401-1406.
8. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983.
9. Gusella JF, MacDonald ME (1994) Huntington's disease and repeating trinucleotides. N Engl J Med 330: 1450-1451.
10. Matthews PM, Evans AC, Andermann F, Hakim AM (1989) Regional cerebral glucose metabolism differs in adult and rigid juvenile forms of Huntington disease. Pediat Neurol 5: 353-356.
11. Menkes JH (1988) Huntington disease: finding the gene and after. Pediat Neurol 4: 73-78.
12. Gramsbergen JB, Veenma-Van der Duin L, Venema K, Korf J (1986) Cerebral cation shifts and amino acids in Huntington's disease. Arch Neurol 43: 1276-1281.
13. Farrer LA (1986) Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet 24: 305-311.
14. Schoenfeld M, Myers RH, Cupples LH et al (1984) Increased risk of suicide amongst patients with Huntington's disease. N Neurol Neurosurg Psychiatry 47: 1283-1287.
15. Kessler S (1987) The dilemma of suicide and Huntington disease. Am J Med Genet 26: 315-317.
16. Kessler S, Field T, Worth L, Mosbarger H (1987) Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet 26: 259-270.
17. Jensen P, Sorensen SA, Fenger K, Bolwig TG (1993) A study of psychiatric morbidity in patients with Huntington's disease, their relatives, and controls: admissions to psychiatric hospitals in Denmark from 1969 to 1991. Br J Psychiatry 163: 790-797.
18. Dewhurst K, Oliver JE, McKnight AL (1970) Socio-psychiatric consequences of Huntington's disease. Br J Psychiatry 116: 255-258.
19. Haines JL, Conneally PM (1986) Causes of death in Huntington disease as reported on death certificates. Genet Epidemiol 3: 417-423.
20. Martindale B (1987) Huntington's chorea: some psychodynamics seen in those at risk and in the responses of the helping professions. Br J Psychiatry 150: 319-323.
21. Hayden MR (1979) Huntington's chorea in South Africa Ph.D. thesis. Cape Town: University of Cape Town.
22. Myers RH, Vonsattel JP, Stevens TJ et al (1988) Clinical and neuropathological assessment of severity in Huntington's disease. Neurology 38: 341-347.
23. De Volder A, Bol A, Michel C et al (1988) Brain glucose utilization in childhood Huntington's disease studied with positron emission tomography. Brain Dev 10: 47-50.
24. Farrer LA, Conneally PM (1987) Predictability of phenotype in Huntington's disease. Arch Neurol 44: 109-113.
25. van Dijk JG, van der Velde EA, Roos RA, Bruyn GW (1986) Juvenile Huntington disease. Hum Genet 73: 235-239.
26. Huntington G (1872) On chorea. Med Surg Report 26: 317-321.
27. Lyon JW (1863) Chronic hereditary chorea. Am Med Times 7: 289-290.
28. Hansotia P, Cleeland CS, Chun RWM (1968) Juvenile Huntington's chorea. Neurology 18: 217-224.
29. Currier RD, Jackson JF, Meydrech EF (1982) Progression rate and age of onset are related in autosomal dominant neurologic disease. Neurology 32: 907-909.
30. Falvey J, O'Shea B (1983) Huntington's chorea: the role of history-taking and medical records in diagnosis. Psychiatric Nursing 2: 11-13.
31. Schiwach RS, Lindenbaum RH, Miciak A (1990) Predicting Huntington's disease. Lancet 335: 230.
32. Mazziotta JC, Phelps ME, Pahl JJ et al (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med 316: 357-362.
33. Hammer J, Machler M, Schmid W, Schomig-Spingler M (1987) Linked DNA markers in clinical diagnosis of juvenile Huntington's disease. Lancet ii: 1088-1089.
34. Nausieda PA, Koller WC, Weiner WJ, Klawans HL (1979) Chorea induced by oral contraceptives. Neurology 29: 1605-1609.
35. Schady W, Meara RJ (1988) Hereditary progressive chorea without dementia. J Neurol Neurosurg Psychiatry 51: 295-297.
36. Sokol MS, Pfeffer CR, Solomon GE et al (1989) An abused psychotic preadolescent at risk for Huntington's disease. J Am Acad Child Adolesc Psychiatry 28: 612-617.
37. Kessler S (1988) Preselection: a family coping strategy in Huntington disease. Am J Med Genet 31: 617-621.
38. Tyler A, Ball D, Crauford D (1992) Presymptomatic testing for Huntington's disease in the United Kingdom. Br Med J 304: 1593-1596.
39. Crauford D, Dodge A, Kerzin-Storrar L, Harris R (1989) Uptake of presymptomatic predictive testing for Huntington's disease. Lancet ii: 603-605.
40. Harper PS, Morris MJ, Tyler A (1990) Genetic testing for Huntington's disease. Br Med J 300: 1089-1090.
41. Mastromauro CA, Myers RH, Berkman B (1987) Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 26: 271-282.
42. Farrer LA (1987) Response to Kessler: suicide and presymptomatic testing in Huntington disease. Am J Med Genet 26: 319-320.
43. Shaw MW (1987) Testing for the Huntington gene: a right to know, a right not to know, or a duty to know. Am J Med Genet 26: 243-246.
44. Smurl JF, Weaver DD (1987) Presymptomatic testing for Huntington chorea: guidelines for moral and social account-ability. Am J Med Genet 26: 247-257.
45. Bloch M, Hayden MR (1990) Predictive testing for Huntington disease in childhood: challenge and implications. Am J Hum Genet 46: 1-4.
46. Morris MJ, Tyler A, Lazarou L, Meredith L (1989) Problems in genetic prediction for Huntington's disease. Lancet ii: 601-603.
47. Harper PS (1993) Research samples from families with genetic diseases: a proposed code of conduct. Br Med J 306: 1391-1394.
48. Bloch M, Fahy M, Fox S, Hayden MR (1989) Predictive testing for Huntington's disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet 32: 217-224.
49. Farmer A, Owen MJ (1996) Genomics: the next psychiatric revolution? Br J Psychiatry 169: 135-138.
50. Harper PS (1993) Clinical consequences of isolating the gene for Huntington's disease. Br Med J 307: 397-398.
51. Berrios GE, Markova IS, Gimbrett R (1995) The role of psychiatry in genetic prediction programmes for Huntington's disease. Psychiatr Bull 19: 203-206.
52. Wiggins S, Whyte P, Huggins M et al (1992) The psychological consequences of predictive testing for Huntington's disease. N Engl J Med 237: 1401-1405.
53. Bundey S (1997) Few psychological consequences of presymptomatic testing for Huntington disease. Lancet 349: 4.
54. Byrne AP, Bamforth S (1994) Genetic testing and Huntington's disease. Ir J Psychol Med 11: 103.
55. Wolff G (1988) Huntington disease carrier status and the problems involved for those affected: a psychotherapeutic experience. Clin Genet 34: 172-175.
56. Nutt JG (1983) Effect of cholinergic agents in Huntington's disease: a reappraisal. Neurology 33: 932-935.
57. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366-375.
58. Peyser CE, Folstein M, Chase GA et al (1995) Trial of d-α-tocopherol in Huntington's disease. Am J Psychiatry 152: 1771-1775.
59. Stewart JT, Mounts ML, Clark RL (1987) Aggressive behaviour in Huntington's disease: treatment with propranolol. J Clin Psychiatry 48: 106-108.
60. Anonymous (1991) Biomedical and health research programme, Biomedical & health research newsletter Nr. S/91. Brussels: European Community, Medical Research Division.
61. Tanne JH (1992) It's all in the genes. Br Med J 304: 11.
62. Leiden JM (1995) Gene therapy - promise, pitfalls, and prognosis. N Engl J Med 333: 871-873.
63. O'Shea B (1989) Huntington's disease - the experiences of voluntary organisations. Psychiatr Bull 13: 409-411.
64. O'Shea B (1989) Caring for Huntington's chorea patients. Psychatr Bull 13: 719-720.
65. Kapp R (1990) Huntington's disease associations in Australia. Psychiatr Bull 14: 93-94.
66. O'Shea B (1990) Huntington's disease associations in Australia. Psychiatr Bull 14: 94.
67. Huntington's Disease Association of Ireland (1993) Facing Huntington's disease: a handbook for families and friends. Dublin: HDA 1.
68. Kaplan HI, Sadock BJ, Grebb JA (1994) Synopsis of Psychiatry. 7th edn. Baltimore: Williams & Wilkins.